| Year |
Citation |
Score |
| 2023 |
Sanchez-Hernandez ES, Ochoa PT, Suzuki T, Ortiz-Hernandez GL, Unternaehrer JJ, Alkashgari HR, Diaz Osterman CJ, Martinez SR, Chen Z, Kremsky I, Wang C, Casiano CA. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells. Cells. 12. PMID 37626856 DOI: 10.3390/cells12162046 |
0.858 |
|
| 2023 |
Martinez SR, Elix CC, Ochoa PT, Sanchez-Hernandez ES, Alkashgari HR, Ortiz-Hernandez GL, Zhang L, Casiano CA. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance. International Journal of Molecular Sciences. 24. PMID 37108293 DOI: 10.3390/ijms24087130 |
0.796 |
|
| 2022 |
Alkashgari HR, Ruiz-Jimenez C, Stoian C, Coats JS, Baez I, Chirshev E, Martinez SR, Dovat S, Francis-Boyle OL, Casiano CA, Payne KJ. TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 24. PMID 36613920 DOI: 10.3390/ijms24010474 |
0.565 |
|
| 2022 |
Woods-Burnham L, Stiel L, Martinez SR, Sanchez-Hernandez ES, Ruckle HC, Almaguel FG, Stern MC, Roberts LR, Williams DR, Montgomery S, Casiano CA. Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men. Cancer Health Disparities. 4. PMID 35252767 |
0.827 |
|
| 2021 |
Ortiz-Hernandez GL, Sanchez-Hernandez ES, Ochoa PT, Elix CC, Alkashgari HR, McMullen JRW, Soto U, Martinez SR, Diaz Osterman CJ, Mahler M, Roy S, Casiano CA. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells. Cells. 10. PMID 34685704 DOI: 10.3390/cells10102723 |
0.832 |
|
| 2020 |
Martinez SR, Sanchez-Hernandez ES, Chen X, Duran AM, Wang CH, Casiano CA. Abstract D116: Glucocorticoid receptor interacts with beta-catenin to promote stemness and therapy resistance in prostate cancer cells Cancer Epidemiology, Biomarkers & Prevention. 29. DOI: 10.1158/1538-7755.Disp19-D116 |
0.861 |
|
| 2019 |
Martinez SR, Osterman CJD, Chen XS, Wang C, Zhang L, Casiano CA. Abstract LB-260: Role of the glucocorticoid receptor/beta-catenin interaction in prostate cancer stem cell survival and chemoresistance Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Lb-260 |
0.68 |
|
| 2019 |
Hernandez GLO, Martinez S, Sanchez-Hernandez E, Rios-Colon L, Cajigas-DuRoss C, Sanchez T, Neamati N, Casiano CA. Abstract 4395: The cMYC-associated transcription factor JPO2 is upregulated in taxane resistant prostate cancer cells and interacts with the stress oncoprotein LEDGF/p75 Cancer Research. 79: 4395-4395. DOI: 10.1158/1538-7445.Sabcs18-4395 |
0.796 |
|
| 2019 |
Sanchez TW, Martinez SR, Ortiz-Hernandez G, Sanchez-Hernandez E, Montgomery C, Becerra B, Dorsey T, Wang-Johanning F, Ambs S, Casiano CA. Abstract 1623: Autoantibodies to human endogenous retrovirus K envelope protein (HERV-K ENV) are associated with features of prostate cancer aggressiveness in African American men Cancer Research. 79: 1623-1623. DOI: 10.1158/1538-7445.Sabcs18-1623 |
0.791 |
|
| 2018 |
Woods-Burnham L, Cajigas-Du Ross CK, Love A, Basu A, Sanchez-Hernandez ES, Martinez SR, Ortiz-Hernández GL, Stiel L, Durán AM, Wilson C, Montgomery S, Roy S, Casiano CA. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Scientific Reports. 8: 15063. PMID 30305646 DOI: 10.1038/S41598-018-33150-2 |
0.823 |
|
| 2018 |
Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, Durán AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernández GL, Ríos-Colón L, Chirshev E, Sanchez-Hernandez ES, Soto U, Greco C, Boucheix C, Chen X, et al. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9: 30363-30384. PMID 30100995 DOI: 10.18632/Oncotarget.25744 |
0.778 |
|
| 2016 |
Basu A, Cajigas-Du Ross CK, Rios-Colon L, Mediavilla-Varela M, Daniels-Wells TR, Leoh LS, Rojas H, Banerjee H, Martinez SR, Acevedo-Martinez S, Casiano CA. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. Plos One. 11: e0146549. PMID 26771192 DOI: 10.1371/Journal.Pone.0146549 |
0.835 |
|
| 2015 |
Francis OL, Shiraz P, Milford T, Baez I, Coats JS, Mayagoitia K, Ginelli E, Salcedo-Concepcion KR, Martinez S, Zhang X, Filippov V, Su RJ, Fisher R, Morris CL, Dovat S, et al. Abstract 3295: A novel patient-derived xenograft model for evaluating the role of TSLP in CRLF2 B-ALL Cancer Research. 75: 3295-3295. DOI: 10.1158/1538-7445.Am2015-3295 |
0.346 |
|
| 2014 |
Francis O, Su R, Martinez S, Baez I, Milford T, Bennett T, Fisher R, Morris CL, Dovat S, Payne KJ. Abstract B21: A human-mouse xenograft model to evaluate therapies and study the role of TSLP-induced signals in Ph-like ALL Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B21 |
0.339 |
|
| 2012 |
Leoh LS, van Heertum B, De Rijck J, Filippova M, Rios-Colon L, Basu A, Martinez SR, Tungteakkhun SS, Filippov V, Christ F, De Leon M, Debyser Z, Casiano CA. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity. Molecular Cancer Research : McR. 10: 378-91. PMID 22275515 DOI: 10.1158/1541-7786.Mcr-11-0314 |
0.828 |
|
| 2012 |
Su R, Francis O, Martinez S, Bennett T, Baez I, Milford T, Zhang X, Morris CL, Dovat S, Payne KJ. A Novel Pre-Clinical Xenograft Model to Study TSLP-CRLF2 Interactions in B-ALL Blood. 120: 1498-1498. DOI: 10.1182/Blood.V120.21.1498.1498 |
0.336 |
|
| 2011 |
Basu A, Banerjee H, Rojas H, Martinez SR, Roy S, Jia Z, Lilly MB, De León M, Casiano CA. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. The Prostate. 71: 755-65. PMID 21031435 DOI: 10.1002/Pros.21292 |
0.836 |
|
| 2011 |
Leoh LS, Mediavilla-Varela M, Basu A, Daniels TR, Martinez S, Pacheco FJ, Padilla A, Asuelime G, Rios-Colon L, Leon MD, Casiano CA. Abstract 2083: The stress oncoprotein LEDGF/p75 attenuates oxidative stress-induced necrosis but not apoptosis in prostate cancer cells Cancer Research. 71: 2083-2083. DOI: 10.1158/1538-7445.Am2011-2083 |
0.795 |
|
| 2010 |
Leoh LS, Rios-Colon L, Martinez S, Tungteakkhun S, Filippova M, Manuel L, Gijsbers R, Debyser Z, Casiano CA. Abstract 2945: Methyl CpG binding protein MeCP2 interacts with the stress-response transcription coactivator LEDGF/p75 and modulates its survival and transcription functions Cancer Research. 70: 2945-2945. DOI: 10.1158/1538-7445.Am10-2945 |
0.843 |
|
| 2010 |
Basu A, Mediavilla-Varela M, Martinez S, Rojas H, Banergee H, Roy S, Lilly MB, Leon MD, Casiano CA. Abstract 2715: Peroxiredoxin 3: A potential biological determinant of prostate cancer health disparities Cancer Research. 70: 2715-2715. DOI: 10.1158/1538-7445.Am10-2715 |
0.845 |
|
| 2010 |
Basu A, Banerjee H, Rojas H, Martinez S, Mediavilla-Varela M, Sourav R, Jia Z, Mercola D, Lilly MB, Leon MD, Casiano CA. Abstract A108: Differential expression of peroxiredoxins in prostate cancer: Ethnic differences in the association of PRDX3 expression with clinical outcomes Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-A108 |
0.847 |
|
| Show low-probability matches. |